Clinical Trials Browser

Phase 1/2 × Central Nervous System Neoplasms × Lapatinib × Clear all

NCT00099060 2014-01-27

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1/2 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma